Literature DB >> 8875462

Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease.

S T MacDonald1, K Sutherland, J W Ironside.   

Abstract

A comparative semi-automated morphometric study was performed on the distribution of prion protein, spongiform change and astrocytosis in the brains of nine cases of sporadic Creutzfeldt-Jakob disease of differing genotype at the methionine-valine polymorphism at codon 129 of the prion protein gene. Custom-designed image analysis software was used to produce objective figures for each of the different pathological features throughout 13 different areas of the brain used for analysis. A significant positive correlation was observed between prion protein deposition and astrocytosis in all cases and no significant correlation was observed between spongiform change and prion protein deposition. Different patterns of pathology were found to relate to codon 129 genotype; valine homozygosity favoured the targeting of pathology to deep grey matter structures, while methionine homozygosity favoured cortical targeting of pathology. These results provide evidence that prion protein deposition is closely associated with an astrocytic reaction and suggest that codon 129 genotype may influence the pathological phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875462     DOI: 10.1111/j.1365-2990.1996.tb01106.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  6 in total

1.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

2.  Analysis of PRNP gene codon 129 polymorphism in the Greek population.

Authors:  Angelica A Saetta; Nikolaos V Michalopoulos; George Malamis; Polyanthi I Papanastasiou; Niki Mazmanian; Maria Karlou; Anastasios Kouzoupis; Penelope Korkolopoulou; Efstratios Patsouris
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression.

Authors:  O S Cohen; I Prohovnik; A D Korczyn; L Ephraty; Z Nitsan; R Tsabari; S Appel; H Rosenmann; E Kahana; J Chapman
Journal:  Acta Neurol Scand       Date:  2011-02-08       Impact factor: 3.209

4.  MRI detection of the cerebellar syndrome in Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Chen Hoffmann; Hedok Lee; Joab Chapman; Robert K Fulbright; Isak Prohovnik
Journal:  Cerebellum       Date:  2009-05-01       Impact factor: 3.847

5.  Prion protein immunohistochemistry in Creutzfeldt-Jakob disease.

Authors:  G Gkovács; K Majtényi; L László
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

6.  Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease.

Authors:  Bradley R Groveman; Natalia C Ferreira; Simote T Foliaki; Ryan O Walters; Clayton W Winkler; Brent Race; Andrew G Hughson; Gianluigi Zanusso; Cathryn L Haigh
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.